Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-27 4:31 pm Purchase | 2025-10-23 | 13D | Viridian Therapeutics, Inc. VRDN | Fairmount Funds Management LLC | 16,025,330 15.140% | 468,645 (+3.01%) | Filing History |
| 2025-10-17 5:00 pm Purchase | 2025-10-15 | 13D | Spyre Therapeutics, Inc. SYRE | Fairmount Funds Management LLC | 8,106,882 9.990% | 3,598,303 (+79.81%) | Filing History |
| 2025-10-15 09:27 am Sale | 2025-10-14 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 2,377,049 4.000% | -3,491,988 (-59.50%) | Filing History |
| 2025-10-14 7:11 pm Purchase | 2025-10-10 | 13D | Apogee Therapeutics, Inc. APGE | Fairmount Funds Management LLC | 5,776,881 9.990% | 1,014,323 (+21.30%) | Filing History |
| 2025-10-08 4:15 pm Purchase | 2025-10-06 | 13D | Jade Biosciences, Inc. JBIO | Fairmount Funds Management LLC | 10,353,875 19.990% | 3,104,519 (+42.82%) | Filing History |
| 2025-09-19 6:56 pm Purchase | 2025-09-17 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 11,162,741 19.990% | 2,650,917 (+31.14%) | Filing History |
| 2025-09-15 4:15 pm Purchase | 2025-09-11 | 13D | Dianthus Therapeutics, Inc. DNTH | Fairmount Funds Management LLC | 4,052,052 9.900% | 1,094,667 (+37.01%) | Filing History |
| 2025-08-14 4:03 pm Purchase | 2025-06-30 | 13G | Enliven Therapeutics, Inc. ELVN | Fairmount Funds Management LLC | 3,711,444 6.300% | 508,646 (+15.88%) | Filing History |
| 2025-07-14 4:31 pm Purchase | 2025-07-10 | 13D | Cogent Biosciences, Inc. COGT | Fairmount Funds Management LLC | 14,324,918 9.900% | 2,994,777 (+26.43%) | Filing History |
| 2025-06-23 6:32 pm Purchase | 2025-06-13 | 13D | Crescent Biopharma, Inc. CBIO | Fairmount Funds Management LLC | 3,124,220 19.990% | 3,124,220 (New Position) | Filing History |
| 2025-05-01 6:31 pm Purchase | 2025-04-28 | 13D | Jade Biosciences, Inc. JBIO | Fairmount Funds Management LLC | 7,249,356 19.990% | 7,249,356 (New Position) | Filing History |
| 2025-03-10 7:00 pm Purchase | 2025-03-06 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 8,511,824 19.990% | 570,134 (+7.18%) | Filing History |
| 2025-02-14 3:45 pm Purchase | 2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT | Fairmount Funds Management LLC | 7,018,575 9.900% | 398,264 (+6.02%) | Filing History |
| 2025-02-14 3:45 pm Unchanged | 2024-12-31 | 13G | Enliven Therapeutics, Inc. ELVN | Fairmount Funds Management LLC | 3,202,798 6.600% | 0 (Unchanged) | Filing History |
| 2025-02-14 3:45 pm Purchase | 2024-12-31 | 13G | Astria Therapeutics, Inc. ATXS | Fairmount Funds Management LLC | 5,869,037 9.900% | 992 (+0.02%) | Filing History |
| 2025-02-14 3:45 pm Sale | 2024-12-31 | 13G | AnaptysBio, Inc. ANAB | Fairmount Funds Management LLC | 0 0.000% | -1,671,484 (Position Closed) | Filing History |
| 2025-02-14 3:45 pm Sale | 2024-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA | Fairmount Funds Management LLC | 0 0.000% | -3,204,841 (Position Closed) | Filing History |
| 2024-12-18 4:30 pm Purchase | 2024-12-11 | 13G | AnaptysBio, Inc. ANAB | Fairmount Funds Management LLC | 1,671,484 5.500% | 1,671,484 (New Position) | Filing History |
| 2024-11-21 6:30 pm Purchase | 2024-11-19 | 13D | Oruka Therapeutics, Inc. ORKA | Fairmount Funds Management LLC | 7,941,690 19.990% | 17 (+0.00%) | Filing History |
| 2024-11-14 4:15 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Fairmount Funds Management LLC | 0 0.000% | -6,632,015 (Position Closed) | Filing History |